Jeffrey S. Heier Ocular Therapeutix, Inc (OCUL) insider trading activity
Jeffrey S. Heier is Chief Scientific Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 249,409 shares of OCUL, which is worth approximately $2.92 Million. The most recent transaction as insider was on Oct 02, 2025, when has been sold 10,502 shares (Common Stock) at a price of $11.04 per share, resulting in proceeds of $115,942. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
249K
5.16%
3M change
8.31%
12M change
Total Value Held
$2.92 Million
Jeffrey S. Heier Transaction History
JSH
Jeffrey S. Heier
Chief Scientific Officer
Bedford,, MA